Karnataka Antibiotics & Pharmaceuticals Ltd., (KAPL)

RIFAMPICIN

• Category :

  Intermediates/Pharmaceutical intermediates

• Synonyms :

  3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin;Abrifam;Dipicin;Eremfat;R/AMP;RIF;Rifa;Rifadin;Rifadin I.V.;Rifaldin;rifaldazine;Rifamate;Rifamicin AMP;Rifampin;Rifaprodin;Rifater;Rifobac;Rifoldin;Riforal;Rimactan;Rimycin;Rifamycin SV Sodium;Rifandin;(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate;

• CAS NO :

  13292-46-1

• EC NO :

  236-312-0

• Molecular Formula :

  C₄₃H₅₈N₄O₁₂

• Molecular Weight :

  822.9402

• Main Specifications :

• InChI :

  InChI=1/C43H58N4O12/c1-21-12-11-13-22(2)42(55)45-33-28(20-44-47-17-15-46(9)16-18-47)37(52)30-31(38(33)53)36(51)26(6)40-32(30)41(54)43(8,59-40)57-19-14-29(56-10)23(3)39(58-27(7)48)25(5)35(50)24(4)34(21)49/h11-14,19-21,23-25,29,34-35,39,49-53H,15-18H2,1-10H3,(H,45,55)/b12-11+,19-14+,22-13-,44-20?/t21?,23-,24-,25-,29+,34+,35-,39+,43+/m1/s1

• Molecular Structure :